Anwaar Saeed
Clinical trials sponsored by Anwaar Saeed, explained in plain language.
-
New Triple-Threat attack on deadly pancreatic cancer begins human testing
Disease control Recruiting nowThis early-stage study is testing the safety of combining two new investigational drugs with a standard chemotherapy regimen for advanced pancreatic cancer. It will enroll up to 12 adults who have not yet received any treatment for their advanced disease. The main goal is to find…
Phase: PHASE1 • Sponsor: Anwaar Saeed • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New Triple-Drug attack on tough liver cancer
Disease control Recruiting nowThis study is testing a new three-drug combination for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if adding a new drug called zanzalintinib to two existing immunotherapy drugs helps control the cancer better. The study will first find …
Phase: PHASE2 • Sponsor: Anwaar Saeed • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New Two-Drug attack on Tough-to-Treat digestive cancers
Disease control Recruiting nowThis trial is testing whether combining two drugs, cabozantinib and durvalumab, is safe and effective for people with advanced cancers of the digestive system. It is for adults whose stomach, esophageal, liver, or colorectal cancer has progressed after standard treatments. The go…
Phase: PHASE1, PHASE2 • Sponsor: Anwaar Saeed • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC